Abstract
Background
Patient and Methods
Results
Conclusions
Key Words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Colorectal CancerReferences
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2018; 68: 394-424https://doi.org/10.3322/caac.21492
- Cancer Statistics, 2021.CA Cancer J Clin. 2021; 71: 7-33https://doi.org/10.3322/caac.21654
- 2017 NCCN Guidelines Version 2.2017 Panel Members Colon Cancer NCCN Evidence Blocks MD/Vice-Chair UCSF Helen Diller Family Comprehensive Cancer Center.
- Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer.J Korean Soc Coloproctol. 2012; 28: 49-55https://doi.org/10.3393/jksc.2012.28.1.49
O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 6;96(19):1420-5. doi:10.1093/jnci/djh275
- Colorectal cancer statistics, 2017.CA Cancer J Clin. 2017; 67: 177-193https://doi.org/10.3322/caac.21395
- Predictors of recurrence free survival for patients with stage II and III colon cancer.BMC Cancer. 2014; 14: 336https://doi.org/10.1186/1471-2407-14-336
- Inflammation, a key event in cancer development.Mol Cancer Res. 2006; 4: 221-233https://doi.org/10.1158/1541-7786.MCR-05-0261
- Cancer-related inflammation.Nature. 2008; 454: 436-444https://doi.org/10.1038/nature07205
- Inflammation and free radicals in tumor development and progression.Redox Rep. 2002; 7: 357-368https://doi.org/10.1179/135100002125001135
- Factors affecting use and delay (>/=8 Weeks) of adjuvant chemotherapy after colorectal cancer surgery and the impact of chemotherapy-use and delay on oncologic outcomes.PLoS One. 2015; 10e0138720https://doi.org/10.1371/journal.pone.0138720
- The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study.Oncotarget. 2017; 8: 80061-80072https://doi.org/10.18632/oncotarget.17767
- Improved survival with early adjuvant chemotherapy after colonic resection for stage III colonic cancer: a nationwide study.J Surg Oncol. 2015; 112: 538-543https://doi.org/10.1002/jso.24017
- Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.JAMA. 2011; 305: 2335-2342https://doi.org/10.1001/jama.2011.749
- Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.Cancer. 2006; 107: 2581-2588https://doi.org/10.1002/cncr.22316
- The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer.Ann Surg. 2009; 249: 727-734https://doi.org/10.1097/SLA.0b013e3181a3ddbd
- Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.J Clin Oncol. 1990; 8: 1466-1475https://doi.org/10.1200/JCO.1990.8.9.1466
- Postoperative cell mediated immune response is better preserved after laparoscopic vs open colorectal resection in humans.Surg Endosc. 2003; 17: 972-978https://doi.org/10.1007/s00464-001-8263-y
- The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.J Natl Cancer Inst. 1993; 85: 365-376https://doi.org/10.1093/jnci/85.5.365
Network NCC.Rectal Cancer. Version 2.2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/rectal_blocks.pdf.
- Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.Front Psychol. 2013; 4: 863https://doi.org/10.3389/fpsyg.2013.00863
- Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.J Clin Oncol. 2009; 27: 3109-3116https://doi.org/10.1200/JCO.2008.20.6771
- The effects of surgery on tumor growth: a century of investigations.Ann Oncol. 2008; 19: 1821-1828https://doi.org/10.1093/annonc/mdn386
- The influence of surgical trauma on experimental metastasis.Cancer. 1989; 64: 2035-2044https://doi.org/10.1002/1097-0142(19891115)64:10<2035::aid-cncr2820641012>3.0.co;2-l
- Growth rate of hepatic metastases in colorectal carcinoma.Br J Surg. 1988; 75: 641-644https://doi.org/10.1002/bjs.1800750707
- Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial.Lancet Oncol. 2012; 13: 1152-1160https://doi.org/10.1016/S1470-2045(12)70348-0
- Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.Ann Surg. 2000; 232: 58-65https://doi.org/10.1097/00000658-200007000-00009
- Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).J Cancer Res Clin Oncol. 2017; 143: 2581-2593https://doi.org/10.1007/s00432-017-2489-0
- Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.Dis Colon Rectum. 2009; 52 (discussion 1064): 1054-1063https://doi.org/10.1007/DCR.0b013e3181a51173
- Risk factors and consequences of anastomotic leak after colectomy: a national analysis.Dis Colon Rectum. 2015; 58: 333-338https://doi.org/10.1097/DCR.0000000000000249
- Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol. 2016; 23 (Suppl 5): 772-783https://doi.org/10.1245/s10434-016-5547-y
- Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.Ann Oncol. 2002; 13: 267-272https://doi.org/10.1093/annonc/mdf019
- Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.Cancer. 2010; 116: 5608-5618https://doi.org/10.1002/cncr.25356
- Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.J Clin Oncol. 2004; 22: 3284-3292https://doi.org/10.1200/JCO.2004.10.012
- Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program.JAMA Surg. 2014; 149: 170-175https://doi.org/10.1001/jamasurg.2013.3640
- Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.J Clin Oncol. 2003; 21: 3737-3743https://doi.org/10.1200/JCO.2003.04.187
- Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.J Natl Cancer Inst. 1997; 89: 497-505
- A comparison of laparoscopically assisted and open colectomy for colon cancer.N Engl J Med. 2004; 350: 2050-2059https://doi.org/10.1056/NEJMoa032651
- The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer.Ann Surg. 2008; 248: 1-7https://doi.org/10.1097/SLA.0b013e31816a9d65
- Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group.J Clin Oncol. 2007; 25: 3061-3068https://doi.org/10.1200/JCO.2006.09.7758
- A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for colorectal cancer.J Cancer. 2011; 2: 425-434https://doi.org/10.7150/jca.2.425
- Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.Colorectal Dis. 2009; 11: 768-774https://doi.org/10.1111/j.1463-1318.2008.01648.x
- A 10-year study of outcome following hepatic resection for colorectal liver metastases - The effect of evaluation in a multidisciplinary team setting.Eur J Surg Oncol. 2009; 35: 302-306https://doi.org/10.1016/j.ejso.2008.01.028
- Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy.World J Gastroenterol. 2011; 17: 2013-2018https://doi.org/10.3748/wjg.v17.i15.2013
- Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes.Health Policy. 2015; 119: 464-474https://doi.org/10.1016/j.healthpol.2014.09.006
- FOxTROT: neoadjuvant FOLFOX chemotherapy with or without panitumumab (Pan) for patients (pts) with locally advanced colon cancer (CC).J Clin Oncol. 2020; 38 (4013–4013)https://doi.org/10.1200/JCO.2020.38.15_suppl.4013
- ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.Nat Rev Clin Oncol. 2020; https://doi.org/10.1038/s41571-020-0392-0
Article info
Publication history
Footnotes
This study was funded/supported by Chao Family Comprehensive Cancer Center. This study was presented at Gastrointestinal Cancers Symposium. San Francisco, CA. January 18, 2019